Drug Approval | September 29, 2023
USFDA delegation visits Divi's Laboratories’ Unit I at Choutuppal, Telangana
The delegation's visit covered a wide range of topics
The delegation's visit covered a wide range of topics
The aggregate foreign investment, including investment from other foreign investors may be up to 90.1% shareholding in the company
Commenced operations in flood-affected Himachal Pradesh
Also to be launched Scheme for promotion of Research and Innovation in Pharma MedTech Sector (PRIP)
The campus in Genome Valley will provide services in discovery chemistry & discovery biology, safety toxicology, bioanalytical services and formulation development to global pharmaceutical companies
National Health Authority (NHA) to host the two-day Arogya Manthan event in New Delhi
This production block consists of chemical synthesis reactions and clean rooms areas to produce final API
Reinforces Henkel commitment to supporting customers and ecosystem in medical healthcare
Luran S MED 797S SPF30 is one of the first ASA materials in the market specifically for medical device housings
Sun Pharma is granted rights for marketing Sovateltide in India under the brand name Tyvalzi (Sovateltide)
Subscribe To Our Newsletter & Stay Updated
